Scott Rodig

Scott Rodig, M.D., Ph.D. is a Professor of Pathology at Harvard Medical School, a diagnostic and investigational pathologist at Brigham and Women’s Hospital, and the Director of the Center for Immuno-Oncology Tissue Biomarker Laboratory, at Dana-Farber Cancer Institute. His work is focused on analyzing the immune microenvironment of tumors through biomarker detection and cellular phenotype determination with an emphasis on discovering and exploring novel and translational approaches in immuno-oncology that improve diagnostic practice. Dr. Rodig earned his M.D. and Ph.D. from the Washington University School of Medicine in St. Louis. He completed his postdoctoral and residency training at Harvard Medical School and Brigham and Women’s Hospital, before joining the faculty at Harvard Medical School.